Yea agree bottle finding the right partner will be crucial to its success but I do feel whoever it is will find a way to fast track this to market much quicker than 5 years. Is the FDA not looking at ways to assist valuable products to overcome the lengthy and sometimes unnecessary trials.
But you’re right our initial payday will come when the partner is identified and signed up.
Cheers mate
OTR
TAVR gains interest at JPM, page-10
-
- There are more pages in this discussion • 44 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.20 |
Change
-0.800(5.71%) |
Mkt cap ! $279.0M | |||
| Open | High | Low | Value | Volume |
| $14.00 | $14.00 | $13.11 | $947.2K | 71.30K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 500 | $13.10 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.35 | 300 | 1 |
View Market Depth
| Last trade - 16.10pm 30/08/2024 (20 minute delay) ? |
| AVR (ASX) Chart |